id | C00011153 |
---|---|
Name | Gallogen / Ellagic acid / Elagostasine / Alizarin yellow |
CAS RN | 476-66-4 |
Standard InChI | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H |
Standard InChI (Main Layer) | InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H |
Phytochemical cluster | No. 81 |
---|---|
KCF-S cluster | No. 2068 |
By standard InChI | CHEMBL6246 |
---|---|
By standard InChI Main Layer | CHEMBL6246 |
By LinkDB | C10788 |
---|
By CAS RN | D004610 |
---|
class name | count |
---|---|
rosids | 15 |
Spermatophyta | 1 |
eudicotyledons | 1 |
family name | count |
---|---|
Myrtaceae | 5 |
Rosaceae | 2 |
Casuarinaceae | 2 |
Melastomataceae | 1 |
Saxifragaceae | 1 |
Geraniaceae | 1 |
Combretaceae | 1 |
Lythraceae | 1 |
Euphorbiaceae | 1 |
Cupressaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL6246 |
CHEMBL1613992
(2)
|
7 / 44 |
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | CHEMBL6246 |
CHEMBL1614529
(1)
|
0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL6246 |
CHEMBL1738312
(1)
|
0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL6246 |
CHEMBL1794499
(1)
|
2 / 0 |
P08069 | Insulin-like growth factor 1 receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL6246 |
CHEMBL1961284
(1)
|
1 / 3 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL6246 |
CHEMBL1614079
(1)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL6246 |
CHEMBL1614076
(1)
|
1 / 1 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | CHEMBL6246 |
CHEMBL1074270
(1)
|
0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | CHEMBL6246 |
CHEMBL1074269
(1)
|
0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | CHEMBL6246 |
CHEMBL1074272
(1)
CHEMBL2341285
(1)
|
0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | CHEMBL6246 |
CHEMBL1613955
(1)
|
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL6246 |
CHEMBL1794585
(1)
|
0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | CHEMBL6246 |
CHEMBL2341282
(1)
|
0 / 0 |
O14965 | Aurora kinase A | Aur | CHEMBL6246 |
CHEMBL1961275
(1)
|
0 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | CHEMBL6246 |
CHEMBL1614153
(1)
|
1 / 4 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL6246 |
CHEMBL1614474
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL6246 |
CHEMBL1614544
(1)
|
11 / 10 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL6246 |
CHEMBL1613776
(2)
|
3 / 1 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL6246 |
CHEMBL974405
(1)
|
0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL6246 |
CHEMBL1074266
(1)
CHEMBL2341286
(1)
|
1 / 2 |
P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | CHEMBL6246 |
CHEMBL1613889
(1)
CHEMBL1614401
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL6246 |
CHEMBL1614027
(1)
|
0 / 1 |
O00444 | Serine/threonine-protein kinase PLK4 | PLK serine/threonine protein kinase subfamily | CHEMBL6246 |
CHEMBL1961235
(1)
|
0 / 0 |
P11802 | Cyclin-dependent kinase 4 | CMGC serine/threonine protein kinase family | CHEMBL6246 |
CHEMBL1961279
(1)
|
1 / 3 |
P24385 | G1/S-specific cyclin-D1 | Other cytosolic protein | CHEMBL6246 |
CHEMBL1961279
(1)
|
1 / 10 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL6246 |
CHEMBL1614067
(3)
|
1 / 2 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | CHEMBL6246 |
CHEMBL2039370
(1)
CHEMBL2039371
(1)
CHEMBL2039375 (1) CHEMBL2039376 (1) CHEMBL2039377 (1) CHEMBL2039381 (1) |
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL6246 |
CHEMBL1614166
(1)
|
1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL6246 |
CHEMBL1961280
(1)
|
1 / 11 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL6246 |
CHEMBL1794311
(1)
|
2 / 3 |
P23280 | Carbonic anhydrase 6 | Lyase | CHEMBL6246 |
CHEMBL1074271
(1)
|
0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL6246 |
CHEMBL1613800
(2)
|
0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | CHEMBL6246 |
CHEMBL1074276
(1)
|
0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | CHEMBL6246 |
CHEMBL1613976
(1)
|
4 / 4 |
O43570 | Carbonic anhydrase 12 | Lyase | CHEMBL6246 |
CHEMBL1074274
(1)
CHEMBL2341283
(1)
|
1 / 2 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL6246 |
CHEMBL861019
(1)
|
1 / 1 |
P54760 | Ephrin type-B receptor 4 | Eph | CHEMBL6246 |
CHEMBL1961281
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL6246 |
CHEMBL1794486
(2)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL6246 |
CHEMBL1738606
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL6246 |
CHEMBL1614270
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL6246 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
P15121 | Aldose reductase | Enzyme | CHEMBL6246 |
CHEMBL1942674
(1)
|
0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | CHEMBL6246 |
CHEMBL1074265
(1)
CHEMBL2341287
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL6246 |
CHEMBL861009
(1)
|
0 / 0 |
Q05397 | Focal adhesion kinase 1 | Fak | CHEMBL6246 |
CHEMBL1961283
(1)
|
0 / 0 |
P09211 | Glutathione S-transferase P | Enzyme | CHEMBL6246 |
CHEMBL1694674
(1)
|
0 / 2 |
Q02763 | Angiopoietin-1 receptor | Tie | CHEMBL6246 |
CHEMBL1961236
(1)
|
1 / 1 |
P15056 | Serine/threonine-protein kinase B-raf | Raf | CHEMBL6246 |
CHEMBL1961277
(1)
|
6 / 3 |
P08107 | Heat shock 70 kDa protein 1A/1B | Unclassified protein | CHEMBL6246 |
CHEMBL1614054
(1)
CHEMBL1614297
(1)
CHEMBL1613848 (1) |
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL6246 |
CHEMBL1794569
(1)
|
1 / 1 |
O60285 | NUAK family SNF1-like kinase 1 | CAMK serine/threonine protein kinase NUAK subfamily | CHEMBL6246 |
CHEMBL1961274
(1)
|
0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL6246 |
CHEMBL1614319
(1)
CHEMBL1614410
(1)
CHEMBL1613988 (1) |
1 / 3 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | CHEMBL6246 |
CHEMBL2077040
(1)
CHEMBL2077163
(1)
|
0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL6246 |
CHEMBL1794401
(1)
|
0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL6246 |
CHEMBL1963893
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL6246 |
CHEMBL1794467
(1)
|
0 / 0 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | CHEMBL6246 |
CHEMBL1961231
(1)
|
5 / 4 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL6246 |
CHEMBL1961282
(1)
|
5 / 10 |
P09619 | Platelet-derived growth factor receptor beta | Pdgfr | CHEMBL6246 |
CHEMBL1961233
(1)
|
5 / 1 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | CHEMBL6246 |
CHEMBL816866
(1)
CHEMBL1960851
(1)
|
0 / 0 |
Q96GD4 | Aurora kinase B | Aur | CHEMBL6246 |
CHEMBL1961276
(1)
|
0 / 0 |
P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | CHEMBL6246 |
CHEMBL1961229
(1)
|
1 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | CHEMBL6246 |
CHEMBL1961232
(1)
|
2 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL6246 |
CHEMBL1613808
(1)
|
0 / 0 |
P35916 | Vascular endothelial growth factor receptor 3 | Vegfr | CHEMBL6246 |
CHEMBL1961230
(1)
|
2 / 1 |
P00390 | Glutathione reductase, mitochondrial | Oxidoreductase | CHEMBL6246 |
CHEMBL1694676
(1)
CHEMBL1695820
(1)
CHEMBL1695821 (1) |
0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | CHEMBL6246 |
CHEMBL1074273
(1)
CHEMBL2341284
(1)
|
0 / 1 |
P41279 | Mitogen-activated protein kinase kinase kinase 8 | Ste11 | CHEMBL6246 |
CHEMBL1961237
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL6246 |
CHEMBL1613910
(2)
CHEMBL1614227
(1)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL6246 |
CHEMBL1614038
(3)
|
2 / 2 |
P12821 | Angiotensin-converting enzyme | M2 | CHEMBL6246 |
CHEMBL1015636
(1)
|
4 / 2 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL6246 |
CHEMBL1961234
(1)
|
0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | CHEMBL6246 |
CHEMBL687375
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL6246 |
CHEMBL1614240
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL6246 |
CHEMBL1961273
(1)
|
4 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL6246 |
CHEMBL1613777
(1)
|
1 / 1 |
P07949 | Proto-oncogene tyrosine-protein kinase receptor Ret | Ret | CHEMBL6246 |
CHEMBL861018
(1)
|
9 / 5 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL6246 |
CHEMBL1794483
(2)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL6246 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL6246 |
CHEMBL1614466
(1)
CHEMBL1614211
(2)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL6246 |
CHEMBL1614250
(3)
CHEMBL1614421
(3)
CHEMBL1614502 (2) |
4 / 3 |
P07451 | Carbonic anhydrase 3 | Lyase | CHEMBL6246 |
CHEMBL1074267
(1)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL6246 |
CHEMBL861010
(1)
|
1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | CHEMBL6246 |
CHEMBL1074268
(1)
|
1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL6246 |
CHEMBL1794536
(3)
|
0 / 0 |
P11142 | Heat shock cognate 71 kDa protein | Unclassified protein | CHEMBL6246 |
CHEMBL1613796
(1)
CHEMBL1614143
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL6246 |
CHEMBL1613914
(3)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL6246 |
CHEMBL1613829
(3)
CHEMBL1613928
(1)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL6246 |
CHEMBL1738442
(1)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL6246 |
CHEMBL1614364
(3)
CHEMBL1738394
(1)
|
1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL6246 |
CHEMBL2354311
(1)
|
1 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL6246 |
CHEMBL1614319
(1)
CHEMBL1613988
(1)
|
2 / 5 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL6246 |
CHEMBL1738090
(1)
CHEMBL1737904
(1)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL6246 |
CHEMBL1738090
(1)
CHEMBL1737904
(1)
|
1 / 6 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | CHEMBL6246 |
CHEMBL2075394
(1)
CHEMBL2077721
(1)
|
0 / 0 |
P20248 | Cyclin-A2 | Other cytosolic protein | CHEMBL6246 |
CHEMBL1961278
(1)
|
0 / 0 |
P78396 | Cyclin-A1 | Other cytosolic protein | CHEMBL6246 |
CHEMBL1961278
(1)
|
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL6246 |
CHEMBL1961278
(1)
|
0 / 0 |
P22694 | cAMP-dependent protein kinase catalytic subunit beta | Pka | CHEMBL6246 |
CHEMBL766844
(1)
CHEMBL861008
(1)
|
0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL6246 |
CHEMBL766844
(1)
CHEMBL861008
(1)
|
0 / 0 |
P22612 | cAMP-dependent protein kinase catalytic subunit gamma | Pka | CHEMBL6246 |
CHEMBL766844
(1)
CHEMBL861008
(1)
|
0 / 0 |
Q9UM73 | ALK tyrosine kinase receptor | TKL serine/threonine protein kinase STKR type 1 subfamily | CHEMBL6246 |
CHEMBL861015
(1)
CHEMBL861020
(1)
CHEMBL861022 (1) CHEMBL861023 (1) |
1 / 1 |
P06748 | Nucleophosmin | Other nuclear protein | CHEMBL6246 |
CHEMBL861015
(1)
CHEMBL861020
(1)
CHEMBL861022 (1) CHEMBL861023 (1) |
0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL6246 |
CHEMBL2114738
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D004610 | 55 |
ACPP
5'-NT ACP-3 ACP3 PAP |
acid phosphatase, prostate (EC:3.1.3.2 3.1.3.5) | Ellagic Acid results in increased expression of ACPP mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 213 |
ALB
PRO0883 PRO0903 PRO1341 |
albumin | ALB protein promotes the reaction [Ellagic Acid results in increased activity of F12 protein] |
increases activity
/ increases reaction |
protein |
6343536
|
D004610 | 317 |
APAF1
APAF-1 CED4 |
apoptotic peptidase activating factor 1 | Ellagic Acid results in decreased expression of APAF1 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 429 |
ASCL1
ASH1 HASH1 MASH1 bHLHa46 |
achaete-scute family bHLH transcription factor 1 | Ellagic Acid results in increased expression of ASCL1 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 440 |
ASNS
TS11 |
asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) | Ellagic Acid results in increased expression of ASNS mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 467 |
ATF3
|
activating transcription factor 3 | Ellagic Acid results in increased expression of ATF3 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 9474 |
ATG5
APG5 APG5-LIKE APG5L ASP hAPG5 |
autophagy related 5 | Ellagic Acid results in increased expression of ATG5 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Ellagic Acid results in increased expression of BCL2 protein |
increases expression
|
protein |
22386815
|
D004610 | 654 |
BMP6
VGR VGR1 |
bone morphogenetic protein 6 | Ellagic Acid results in decreased expression of BMP6 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 2972 |
BRF1
BRF BRF-1 GTF3B TAF3B2 TAF3C TAFIII90 TF3B90 TFIIIB90 hBRF |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit | Ellagic Acid results in decreased expression of BRF1 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 811 |
CALR
CRT RO SSA cC1qR |
calreticulin | Ellagic Acid results in decreased expression of CALR mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Ellagic Acid results in decreased activity of CASP3 protein |
decreases activity
|
protein |
22386815
|
D004610 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Ellagic Acid results in decreased expression of CASP3 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Ellagic Acid results in increased expression of CASP3 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Ellagic Acid results in decreased secretion of CCL2 protein |
decreases secretion
|
protein |
20816778
|
D004610 | 929 |
CD14
|
CD14 molecule | Ellagic Acid results in decreased expression of CD14 mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Ellagic Acid results in decreased expression of CYP1A1 mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 1616 |
DAXX
BING2 DAP6 EAP1 |
death-domain associated protein | Ellagic Acid results in decreased expression of DAXX mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 1676 |
DFFA
DFF-45 DFF1 ICAD |
DNA fragmentation factor, 45kDa, alpha polypeptide | Ellagic Acid results in decreased expression of DFFA mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 1877 |
E4F1
E4F |
E4F transcription factor 1 | Ellagic Acid results in increased expression of E4F1 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 1960 |
EGR3
EGR-3 PILOT |
early growth response 3 | Ellagic Acid results in decreased expression of EGR3 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 2033 |
EP300
KAT3B RSTS2 p300 |
E1A binding protein p300 (EC:2.3.1.48) | Ellagic Acid results in increased expression of EP300 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 2060 |
EPS15
AF-1P AF1P MLLT5 |
epidermal growth factor receptor pathway substrate 15 | Ellagic Acid results in increased expression of EPS15 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 2145 |
EZH1
KMT6B |
enhancer of zeste homolog 1 (Drosophila) (EC:2.1.1.43) | Ellagic Acid results in increased expression of EZH1 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 2161 |
F12
HAE3 HAEX HAF |
coagulation factor XII (Hageman factor) (EC:3.4.21.38) | ALB protein promotes the reaction [Ellagic Acid results in increased activity of F12 protein] |
increases activity
/ increases reaction |
protein |
6343536
|
D004610 | 2161 |
F12
HAE3 HAEX HAF |
coagulation factor XII (Hageman factor) (EC:3.4.21.38) | Ellagic Acid results in increased activity of F12 protein |
increases activity
|
protein |
6343536
|
D004610 | 2260 |
FGFR1
BFGFR CD331 CEK FGFBR FGFR-1 FLG FLT-2 FLT2 HBGFR HH2 HRTFDS KAL2 N-SAM OGD bFGF-R-1 |
fibroblast growth factor receptor 1 (EC:2.7.10.1) | Ellagic Acid results in decreased expression of FGFR1 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 2316 |
FLNA
ABP-280 ABPX CSBS CVD1 FLN FLN-A FLN1 FMD MNS NHBP OPD OPD1 OPD2 XLVD XMVD |
filamin A, alpha | Ellagic Acid results in decreased expression of FLNA mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 2822 |
GPLD1
GPIPLD GPIPLDM PIGPLD PIGPLD1 |
glycosylphosphatidylinositol specific phospholipase D1 (EC:3.1.4.50) | Ellagic Acid results in decreased expression of GPLD1 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 2941 |
GSTA4
GSTA4-4 GTA4 |
glutathione S-transferase alpha 4 (EC:2.5.1.18) | Ellagic Acid results in increased expression of GSTA4 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 2961 |
GTF2E2
FE TF2E2 TFIIE-B |
general transcription factor IIE, polypeptide 2, beta 34kDa | Ellagic Acid results in increased expression of GTF2E2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 2968 |
GTF2H4
P52 TFB2 TFIIH |
general transcription factor IIH, polypeptide 4, 52kDa | Ellagic Acid results in increased expression of GTF2H4 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Ellagic Acid results in decreased expression of HIF1A mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | Ellagic Acid results in increased expression of HMOX1 protein |
increases expression
|
protein |
22386815
|
D004610 | 9592 |
IER2
ETR101 |
immediate early response 2 | Ellagic Acid results in increased expression of IER2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 3485 |
IGFBP2
IBP2 IGF-BP53 |
insulin-like growth factor binding protein 2, 36kDa | Ellagic Acid results in increased expression of IGFBP2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 3487 |
IGFBP4
BP-4 HT29-IGFBP IBP4 IGFBP-4 |
insulin-like growth factor binding protein 4 | Ellagic Acid results in decreased expression of IGFBP4 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Ellagic Acid inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
18377686
|
D004610 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Ellagic Acid results in decreased expression of IL1B mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 3554 |
IL1R1
CD121A D2S1473 IL-1R-alpha IL1R IL1RA P80 |
interleukin 1 receptor, type I | Ellagic Acid results in decreased expression of IL1R1 mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Ellagic Acid inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
18377686
|
D004610 | 3635 |
INPP5D
SHIP SHIP-1 SHIP1 SIP-145 hp51CN |
inositol polyphosphate-5-phosphatase, 145kDa (EC:3.1.3.86) | Ellagic Acid results in increased expression of INPP5D mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 10788 |
IQGAP2
|
IQ motif containing GTPase activating protein 2 | Ellagic Acid results in increased expression of IQGAP2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 10379 |
IRF9
IRF-9 ISGF3 ISGF3G p48 |
interferon regulatory factor 9 | Ellagic Acid results in increased expression of IRF9 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 354 |
KLK3
APS KLK2A1 PSA hK3 |
kallikrein-related peptidase 3 (EC:3.4.21.77) | Ellagic Acid results in decreased expression of KLK3 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 9516 |
LITAF
PIG7 SIMPLE TP53I7 |
lipopolysaccharide-induced TNF factor | Ellagic Acid results in increased expression of LITAF mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 4130 |
MAP1A
MAP1L MTAP1A |
microtubule-associated protein 1A | Ellagic Acid results in decreased expression of MAP1A mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 23531 |
MMD
MMA MMD1 PAQR11 |
monocyte to macrophage differentiation-associated | Ellagic Acid results in increased expression of MMD mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein |
decreases activity
/ decreases secretion |
protein |
21573219
|
D004610 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | zinc chloride inhibits the reaction [Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein] |
decreases activity
/ decreases reaction / decreases secretion |
protein |
21573219
|
D004610 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | Ellagic Acid affects the localization of NFE2L2 protein |
affects localization
|
protein |
22386815
|
D004610 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | Ellagic Acid results in increased expression of NFE2L2 mRNA |
increases expression
|
mRNA |
22386815
|
D004610 | 4780 |
NFE2L2
NRF2 |
nuclear factor, erythroid 2-like 2 | NFE2L2 protein affects the susceptibility to Ellagic Acid |
affects response to substance
|
protein |
22386815
|
D004610 | 4791 |
NFKB2
H2TF1 LYT-10 LYT10 NF-kB2 p105 p52 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Ellagic Acid results in decreased expression of NFKB2 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 4826 |
NNAT
Peg5 |
neuronatin | Ellagic Acid results in increased expression of NNAT mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 10528 |
NOP56
NOL5A SCA36 |
NOP56 ribonucleoprotein | Ellagic Acid results in decreased expression of NOP56 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 4862 |
NPAS2
MOP4 PASD4 bHLHe9 |
neuronal PAS domain protein 2 | Ellagic Acid results in increased expression of NPAS2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 9970 |
NR1I3
CAR CAR1 MB67 |
nuclear receptor subfamily 1, group I, member 3 | Ellagic Acid results in increased activity of NR1I3 protein |
increases activity
|
protein |
21821919
|
D004610 | 8505 |
PARG
PARG99 |
poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) | Ellagic Acid results in decreased activity of PARG protein |
decreases activity
|
protein |
19840838
|
D004610 | 5320 |
PLA2G2A
MOM1 PLA2 PLA2B PLA2L PLA2S PLAS1 sPLA2 |
phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) | Ellagic Acid results in decreased expression of PLA2G2A mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 5355 |
PLP2
A4 A4LSB |
proteolipid protein 2 (colonic epithelium-enriched) | Ellagic Acid results in increased expression of PLP2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 5371 |
PML
MYL PP8675 RNF71 TRIM19 |
promyelocytic leukemia | Ellagic Acid results in decreased expression of PML mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 5467 |
PPARD
FAAR NR1C2 NUC1 NUCI NUCII PPARB |
peroxisome proliferator-activated receptor delta | Ellagic Acid results in decreased expression of PPARD mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 5592 |
PRKG1
1 AAT8 PKG PRKG1B PRKGR1B cGK cGK_1 cGK1 cGKI cGKI-BETA cGKI-alpha |
protein kinase, cGMP-dependent, type I (EC:2.7.11.12) | Ellagic Acid results in decreased expression of PRKG1 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 5764 |
PTN
HARP HBGF8 HBNF NEGF1 |
pleiotrophin | Ellagic Acid results in decreased expression of PTN mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 5764 |
PTN
HARP HBGF8 HBNF NEGF1 |
pleiotrophin | Ellagic Acid results in increased expression of PTN mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 5799 |
PTPRN2
IA-2beta IAR ICAAR PTPRP R-PTP-N2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48) | Ellagic Acid results in increased expression of PTPRN2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 5901 |
RAN
ARA24 Gsp1 TC4 |
RAN, member RAS oncogene family | Ellagic Acid results in decreased expression of RAN mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 8434 |
RECK
ST15 |
reversion-inducing-cysteine-rich protein with kazal motifs | Ellagic Acid results in increased expression of RECK mRNA |
increases expression
|
mRNA |
21573219
|
D004610 | 8434 |
RECK
ST15 |
reversion-inducing-cysteine-rich protein with kazal motifs | Ellagic Acid results in increased expression of RECK protein |
increases expression
|
protein |
21573219
|
D004610 | 8434 |
RECK
ST15 |
reversion-inducing-cysteine-rich protein with kazal motifs | zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA] |
decreases reaction
/ increases expression |
mRNA |
21573219
|
D004610 | 8434 |
RECK
ST15 |
reversion-inducing-cysteine-rich protein with kazal motifs | zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein] |
decreases reaction
/ increases expression |
protein |
21573219
|
D004610 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Ellagic Acid results in decreased expression of RELA mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 8490 |
RGS5
MST092 MST106 MST129 MSTP032 MSTP092 MSTP106 MSTP129 |
regulator of G-protein signaling 5 | Ellagic Acid results in decreased expression of RGS5 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 6319 |
SCD
FADS5 MSTP008 SCD1 SCDOS |
stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) | Ellagic Acid results in decreased expression of SCD mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 4735 |
SEPT2
DIFF6 NEDD-5 NEDD5 Pnutl3 hNedd5 |
septin 2 | Ellagic Acid results in increased expression of SEPT2 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 6649 |
SOD3
EC-SOD |
superoxide dismutase 3, extracellular (EC:1.15.1.1) | Ellagic Acid results in decreased expression of SOD3 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 6774 |
STAT3
APRF HIES |
signal transducer and activator of transcription 3 (acute-phase response factor) | Ellagic Acid results in decreased expression of STAT3 mRNA |
decreases expression
|
mRNA |
20816778
|
D004610 | 6774 |
STAT3
APRF HIES |
signal transducer and activator of transcription 3 (acute-phase response factor) | Ellagic Acid results in increased expression of STAT3 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 9013 |
TAF1C
MGC:39976 SL1 TAFI110 TAFI95 |
TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa | Ellagic Acid results in decreased expression of TAF1C mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 6938 |
TCF12
CRS3 HEB HTF4 HsT17266 bHLHb20 |
transcription factor 12 | Ellagic Acid results in increased expression of TCF12 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 7015 |
TERT
CMM9 DKCA2 DKCB4 EST2 PFBMFT1 TCS1 TP2 TRT hEST2 hTRT |
telomerase reverse transcriptase (EC:2.7.7.49) | Ellagic Acid inhibits the reaction [Estradiol results in increased expression of TERT mRNA alternative form] |
decreases reaction
/ increases expression |
mRNA |
19501078
|
D004610 | 7015 |
TERT
CMM9 DKCA2 DKCB4 EST2 PFBMFT1 TCS1 TP2 TRT hEST2 hTRT |
telomerase reverse transcriptase (EC:2.7.7.49) | Ellagic Acid results in increased expression of TERT mRNA alternative form |
increases expression
|
mRNA |
19501078
|
D004610 | 7019 |
TFAM
MTTF1 MTTFA TCF6 TCF6L1 TCF6L2 TCF6L3 |
transcription factor A, mitochondrial | Ellagic Acid results in decreased expression of TFAM mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 7040 |
TGFB1
CED DPD1 LAP TGFB TGFbeta |
transforming growth factor, beta 1 | Ellagic Acid results in increased expression of TGFB1 mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 7360 |
UGP2
UDPG UDPGP UDPGP2 UGP1 UGPP1 UGPP2 pHC379 |
UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) | Ellagic Acid results in decreased expression of UGP2 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 7375 |
USP4
UNP Unph |
ubiquitin specific peptidase 4 (proto-oncogene) (EC:3.4.19.12) | Ellagic Acid results in decreased expression of USP4 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 7453 |
WARS
GAMMA-2 IFI53 IFP53 |
tryptophanyl-tRNA synthetase (EC:6.1.1.2) | Ellagic Acid results in increased expression of WARS mRNA |
increases expression
|
mRNA |
12002526
|
D004610 | 7704 |
ZBTB16
PLZF ZNF145 |
zinc finger and BTB domain containing 16 | Ellagic Acid results in decreased expression of ZBTB16 mRNA |
decreases expression
|
mRNA |
12002526
|
D004610 | 7750 |
ZMYM2
FIM MYM RAMP SCLL ZNF198 |
zinc finger, MYM-type 2 | Ellagic Acid results in increased expression of ZMYM2 mRNA |
increases expression
|
mRNA |
12002526
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#615007 | Basal ganglia calcification, idiopathic, 4; ibgc4 |
P09619
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#210900 | Bloom syndrome; blm |
P54132
|
#114480 | Breast cancer |
P31749
|
#115150 | Cardiofaciocutaneous syndrome 1; cfc1 |
P15056
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#209880 | Central hypoventilation syndrome, congenital; cchs |
P07949
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P07949
P15056 P31749 P84022 |
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#602089 | Hemangioma, capillary infantile |
P35916
P35968 |
#614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
#114550 | Hepatocellular carcinoma |
P08581
|
#142623 | Hirschsprung disease, susceptibility to, 1; hscr1 |
P07949
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#270450 | Insulin-like growth factor i, resistance to |
P08069
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
P09619
|
#613707 | Leopard syndrome 3 |
P15056
|
#601626 | Leukemia, acute myeloid; aml |
P09619
P36888 |
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P00533
P04626 P04637 P15056 |
#153100 | Lymphedema, hereditary, ia |
P35916
|
#605027 | Lymphoma, non-hodgkin, familial |
P15056
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#609048 | Melanoma, cutaneous malignant, susceptibility to, 3; cmm3 |
P11802
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#171400 | Multiple endocrine neoplasia, type iia; men2a |
P07949
|
#162300 | Multiple endocrine neoplasia, type iib; men2b |
P07949
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254500 | Myeloma, multiple |
P24385
|
#131440 | Myeloproliferative disorder, chronic, with eosinophilia |
P09619
|
#228550 | Myofibromatosis, infantile, 1; imf1 |
P09619
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#613014 | Neuroblastoma, susceptibility to, 3; nblst3 |
Q9UM73
|
#613706 | Noonan syndrome 7; ns7 |
P15056
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#171300 | Pheochromocytoma |
P07949
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#176920 | Proteus syndrome |
P31749
|
#191830 | Renal adysplasia |
P07949
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#267430 | Renal tubular dysgenesis; rtd |
P12821
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#603903 | Sickle cell anemia |
P68871
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P12821
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#155240 | Thyroid carcinoma, familial medullary; mtc |
P07949
|
#188550 | Thyroid carcinoma, papillary |
P07949
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#600195 | Venous malformations, multiple cutaneous and mucosal; vmcm |
Q02763
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P24385 (related) P24385 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P24385 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P11802 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P09619 (related) P11802 (related) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P24385 (related) P24385 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00026 | Endometrial Cancer |
P04626
(related)
P04637 (related) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P24385 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
Q13315 (related) |
H00006 | Hairy-cell leukemia |
P04637
(related)
P24385 (related) |
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
P24385 (related) |
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
Q9UM73 (related) |
H00015 | Malignant pleural mesothelioma |
P04637
(related)
P08069 (related) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P07949 (related) P07949 (marker) P15056 (related) |
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
P11802 (related) P15056 (related) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
P24385 (marker) |
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00822 | Renal agenesis and Renal adysplasia |
P07949
(related)
|
H00910 | Hirschsprung disease (HD) |
P07949
(related)
|
H00916 | Congenital central hypoventilation syndrome (CCHS) |
P07949
(related)
|
H00050 | Synovial sarcoma |
P08069
(related)
|
H01274 | Growth delay due to insulin-like growth factor I resistance |
P08069
(related)
|
H00024 | Prostate cancer |
P09211
(related)
P09211 (marker) |
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00083 | Allograft rejection |
P12821
(related)
|
H00575 | Renal tubular dysgenesis |
P12821
(related)
|
H00523 | Noonan syndrome and related disorders |
P15056
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00559 | von Hippel-Lindau syndrome |
P24385
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00535 | Lymphedemas |
P35916
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00531 | Venous malformations |
Q02763
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000014 | D004610 | Abnormalities, Drug-Induced |
therapeutic
|
9650642
|
|
D002471 | D004610 | Cell Transformation, Neoplastic |
therapeutic
|
19329757
|
|
D006965 | D004610 | Hyperplasia |
therapeutic
|
19329757
20103723 |
|
D007248 | D004610 | Infertility, Male |
therapeutic
|
20074268
|
|
D009203 | D004610 | Myocardial Infarction |
therapeutic
|
21762681
|
|
D015427 | D004610 | Reperfusion Injury |
therapeutic
|
9650642
|
|
D012878 | D004610 | Skin Neoplasms |
therapeutic
|
19329757
|
|
D013471 | D004610 | Sunburn |
therapeutic
|
22386815
|
|
D013733 | D004610 | Testicular Diseases |
therapeutic
|
20074268
|